Suche

…(2010). Adolescent Brain Development and the Risk for Alcohol and other Drug Problems. Neuropsychological Review, 20(4), 398-413. https://doi.org/10.1007/s11065-010-9146-6 Blakemore, S.-J. & Robbins, T. W [...] Neuroscience, 4(6), https://doi.org/10.3389/neuro.09.006.2010 . Herrndorf, W. (2010). Tschick. Rowohlt: Reinbek. Liu, C & Filbey, F. M. (2024). Unlocking the age-old secrets of reward and substance use. [...] Pharmacology Biochemistriy and Behavior, 239, 173766. https://doi.org/10.1016/j.pbb.2024.173766 Petit, G., Kornreich, C., Verbanck, P., Cimochowska, A., & Campanella, S. (2013). Why is adolescence a key…

Bereich: Topthema

…Martin, P. (2011). Aerobic Exercise Training Reduces Cannabis Craving and Use in Non-Treatment Seeking Cannabis-Dependent Adults. PLoS ONE 6(3): e17465. https://doi.org/10.1371/journal.pone.0017465 Budney, [...] Bonnet, U. & Preuss, U. W. (2017). The cannabis withdrawal syndrome: current insights. Substance Abuse and Rehabilitation, 8, 9-37. https://doi.org/10.2147/SAR.S109576 Buchowski, M., Meade, N., Charboneau, [...] A. J., Hughes, J. R., Moore, B. A. & Vandrey, R. (2004). Review of the Validity and Significance of Cannabis Withdrawal Syndrome. Am J Psychiatry, 161, 1967-1977. https://doi.org/10.1176/appi.ajp.161…

Bereich: Topthema

…te (GHB), gamma butyrolactone (GBL) and 1,4-butanedio (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use. Neuroscience and Biobehavioral Reviews, 53, 52-78. Darke [...] d by drugs or alcohol. EMCDDA (2008). GHB and ist precursors. EMCDDA (2020). ESPAD Report 2019. Results from the European School Survey Project on Alcohol and Other Drugs. Felmlee, M. A., Morse, B. L. [...] Schellens, A. (2017). Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention. CNS Drugs, 31, 51-64. https://doi.org/10.1007/s4026…

Bereich: Topthema

…(2024). Cannabis and Anxiety: A Critical Review. Med Cannabis Cannabinoids, 7, 19-30. https://doi.org/10.1159/000534855 Buckner, D., J. & Schmidt N., B. (2009). Social anxiety disorder and marijuana use problems: [...] Expectancies. Depression and Anxiety, 26, 864-870. https://doi.org/10.1002/da.20567 Buckner, J. D., Bonn-Miller, M. O., Zvolensky, M. J. & Schmidt, N. B. (2007). Marijuana Use Motives and Social Anxiety among [...] 816 Schülerinnen und Schüler nahmen daran teil. Bei der ersten Untersuchung waren sie im Schnitt 16,6 Jahre alt und zum Zeitpunkt der letzten Nachuntersuchung durchschnittlich 30 Jahre alt. Die Ergebnisse…

Bereich: Topthema

…Copeland, J. (2011). Successful and unsuccessful cannabis quitters: Comparing group characteristics and quitting strategies. Substance Abuse Treatment, Prevention, and Policy, 6, 30. Snoek, A., Levy, N. & Kennett…

Bereich: Topthema

…etamines (MDMA, ecstasy), and amphetamines. Dialogues in Clinical Neuroscience, 11, 305-317. Artikel Hanson, K. & Luciana, M. (2010). Neurocognitive imparirments in MDMA and other drug users: MDMA alone [...] reductions in users of amphetamine-type stimulants revealed by combined tract-based spatial statistics and voxel-based morphometry. NeuroImage, 54, 794-801. Zusammenfassung Den Hollander, B., Schouw, M., Groot [...] alone may not be a cognitive risk factor. Journal of Clinical and Experimental Neuropsychology, 32 (4), 337-349. Zusammenfassung Kaizaki, A., Tanaka, S., Tsujikawa, K., Numazawa, S. & Yoshida, T. (2010).…

Bereich: Topthema

…issues and local experiences, p. 27-37. Freeman, T. P., Craft, S., Wilson, J., Stylianou, S., ElSohly, M., Di Forti, M. & Lynskey, M. T. (2020). Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol [...] concentrations in cannabis over time: systematic review and meta‐analysis, https://doi.org/10.1111/add.15253 . Grotenhermen, F. (2003). Pharmacokinetics and Pharmacodynamics of Cannabinoids. Clin Pharmacokinet [...] Bilbao, A., Cippitelli, A. & Navarro, M. (2004). The Endocannabinoid System: Physiology and Pharmacology. Alcohol and Alcoholism, 40(1), 2-14. Schep, L. J., Slaughter, R. J., Glue, P. & Gee, P. (2020). The…

Bereich: Topthema

…Narrative Recall and Contextual Memory: An Examination of Fragmentary Blackouts. Addictive Behaviors, 36(8), 886-889. White, A. M. (2003). What Happened? Alcohol, Memory Blackouts, and the Brain. Alcohol [...] Lee, H., Roh, S. & Kim, D. J. (2009). Alcohol-Induced Blackout. Int J of Environ Res Public Health, 6(11), 2783-2792. Mundt, M. P., Zakletskaia, L. I., Brown, D. D., & Fleming, M. F. (2011). Alcohol-induced [...] college drinkers. Injury prevention, 18(19), 44-49. Pressemitteilung Washington University in St. Louis (6.7.2011) Tokuda, K., Izumi, Y. & Zorumski, C. F. (2011). Ethanol Enhances Neurosteroidogenesis in Hippocampal…

Bereich: Topthema

…Opioid Data Analysis and Resources Cruz, S. L., Bencomo-Cruz, M., Medina-Mora, M. E., Vázquez-Quiroz, F. & Fleiz-Bautista, C. (2023). First drug-checking study at an electronic festival and fentanyl detection [...] A. D. (2023) New Synthetic Opioids: Clinical Considerations and Dangers. Pain Ther, 12, 399-421. https://doi.org/10.1007/s40122-023-00481-6 EMCDDA (2023). The drug situation in Europe up to 2023 EMCDDA [...] Zheng, Y., Khan, M. Z., Yuan, K. & Lu, L. (2019). The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Translational Psychiatry, 9, 282. https://doi.org/10.1038/s41398…

Bereich: Topthema

…Prevalence and risks. Regulatory Toxicology and Pharmacology, 73, 790-796. https://doi.org/10.1016/j.yrtph.2015.10.017 Zou, X. et al. (2024) Mechanisms and recent advances in the diagnosis and treatment [...] 15370 MDR Brisant (27.6.2023) Lachgas als Droge: Das sind die Risiken! Puetpaiboon et al. (2024) Nitrous oxide-induced myeloneuropathy in a Thai adolescent: a case report. PAEDIATRICS AND INTERNATIONAL CHILD [...] Lachgas. München: Institut für Therapieforschung. De Halleux, C., & Juurlink, D. N. (2023). Diagnosis and management of toxicity associated with the recreational use of nitrous oxide. CMAJ: Canadian Medical…

Bereich: Topthema